Follow the latest coverage, related explainers and connected technology stories.
The U.S. Food and Drug Administration is developing guidance for using generative artificial intelligence in medical devices, focusing on competency-based evaluation, foundation models, and post-market monitoring. Fundamental questions remain open about the limits of oversight and companies’ responsibility for declining model performance over time.